Jubilant Life Sciences announced on Friday that it has received approval from the US Food and Drugs Administration (FDA) to market a generic diuretic medicine.
The company has received abbreviated new drug application approval to market Spironolactone tablets (25 mg, 50 mg and 100 mg). These tablets are the generic version of GD Searle's Aldactone. Spironolactone is used to treat fluid retention caused by conditions such as congestive heart failure and cirrhosis of the liver.
Congestive Heart Failure
Congestive heart failure (CHF) is a condition in which the heart fails to work adequately as a pump that can deliver oxygen rich blood to the body.
Advertisement
Jubilant said in a press release that it will launch the drug in the first quarter of the fiscal year 2015-16. The market size of this diuretic is estimated to be $87 million per year.
Source: Medindia
Tips to Prevent Heart Attacks
Heart Attack occurs when the flow of oxygenated blood to heart muscles is hindered or stopped due to built-up of plaques in coronary arteries. Heart Attack is the No.1 killer among Indians.
Advertisement
 Animation of heart attack symptoms - AnimationHeart attack can cause symptoms such as Chest pain or discomfort, Shortness of breath and pain in neck, back, arm, or shoulder and is due to blockage of blood supply to the heart muscles | Advertisement
|
Advertisement
Recommended Readings
Latest Corporate News
The first World Health Organisation (WHO)/ International Labour Organisation (ILO) joint global monitoring report shows that more action is needed to ensure healthier, safer, more resilient, and more social workplaces.
Successful career transitions could be possible when people leverage their existing skills in the new occupation. A new Artificial Intelligence tool helps employees figure out the right job according to their current skill set.
AI and big data rule the pharmaceutical sector by enhancing the drug development process and increasing the marketing and sales of drugs
Insurance companies in the US are working towards adding food to their coverage menu to improve the people's health under their coverage and cut hospital costs.
Pharmaceutical companies need to make strategic decisions that will provide financial benefit while showing strong commitment to global health and their patients during the pandemic.